Inactivated vaccine Covaxin/BBV152: A systematic review
비활성화 백신 Covaxin/BBV152: 체계적인 검토
Article
[키워드] adjusted
Administered
adverse event
Aluminium
aluminium hydroxide
Antigen
AZD1222
BBV152
Beta
Bharat
binding antibody
clinical trial
Combination
Corona
Covaxin
Coverage
Covishield
Delta
Delta variants
doses
Effectiveness
Efficacy
Evidence
evidence of
fatality
gel
heterologous prime-boost
hydroxide
immunogenicity
inactivated
Inactivated vaccine
India
infected individual
Local
Neutralizing
omicron
Omicron variant
pandemic
phase
Phase I
Phase III trials
provided
Quinolin
reported
Safety
safety profile
SARS-CoV-2 pandemic
screened
searched
second dose
Serious Adverse Event
Serious Adverse Events
severe COVID-19
surpassed
symptomatic infection
systematic review
systemic adverse events
T cell
T cell response
T cell responses
the SARS-CoV-2
Trial
vaccination
Vaccine
Vaccines
variant
variants
virus
Zeneca
[DOI] 10.3389/fimmu.2022.863162 PMC 바로가기 [Article Type] Article
[DOI] 10.3389/fimmu.2022.863162 PMC 바로가기 [Article Type] Article